Wonju Medical Industry Technovalley to Run Gangwon Joint Pavilion at MEDICA in Germany; 11 Companies Target Europe
- Input
- 2026-11-09 14:47:56
- Updated
- 2026-11-09 14:47:56

【Financial News, Wonju = Kim Gi-seop, reporter】Eleven Gangwon medical-device companies will seek to enter the European market at the world’s largest medical-device trade fair.
On the 9th, Wonju Medical Industry Technovalley said it would participate with a Gangwon joint pavilion at MEDICA 2026, the international medical-device trade fair being held in Düsseldorf, Germany, from the 16th to the 19th, together with Gangwon Province and Wonju-si. The number of participating companies has risen from eight last year to 11 this year.
The agency generated export consultations worth $17.38 million at the exhibition last year. This year, it has stepped up advance marketing to turn consultations into actual contracts. It will prepare local market-entry reports for participating companies and provide buyer lists tailored to each company.
Europe has become a market with higher regulatory approval barriers as it has repeatedly tightened regulations on medical devices and in vitro diagnostic medical devices. The agency’s strategy is to respond in advance to these regulatory changes while steadily drawing local demand for Korean-made medical devices. Given that MEDICA has been comprehensively revamped this year to focus on technologies used in hospitals and clinical settings, it will put front and center technologies that improve clinical efficiency, such as point-of-care diagnostics, AI medical solutions and wearable monitoring.
Eight companies from Wonju will participate, including Meju, which makes wearable ECG patches; Otom, a portable X-ray maker; M.I. One, which makes video endoscopes; and L.H. Biomed, which makes ultrasonic surgical devices. Three companies from Chuncheon are also taking part: J&N Bio, with a diagnostic spirometer; Neuro Ears, with software for diagnosing and rehabilitating dizziness; and Hyupit, with a blood culture system.
Kim Young-sung, president of Wonju Medical Industry Technovalley, said, “This year, we will persuade buyers with Gangwon technologies that can be used immediately in clinical settings, such as point-of-care diagnostics and wearables, and surpass last year’s $17.38 million in consultations.” He added, “We will support companies through to the end as they secure export footholds and overcome Europe’s increasingly stringent regulatory approval requirements.”
[email protected] Kim Gi-seop Reporter